Cytokines Flashcards

1
Q

Function of cytokines

A

Immune & inflammatory response
Haemotopoiesus (production of RBC)
Wound healing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cytokines produced by

A

WBC (not a gland) & function in auto run fashion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

EPO

A

Cytokine produced by kidney & liver, acts in endocrine manor to promote RBC production in bone marrow aka true hormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

EPO Function

A

Stimulate RBC in anaemia people

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Growth factors

A

Promote wound healing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Neurotrophic factors

A

Abatement of neurodegenerative diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pro inflammatory cytokines include

A

IL-1
IL-6
IL-8
TNF
Involved in pathogenicity of septic shock & RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Interferons IFN-a IFN-b IFN-y functions

A

-Induce cellular resistance to viral attack
-Regulate most aspects of immune function
-Regulate growth & differentiation of many cells
-Sustenance of early phase of pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

IFN-a IFN-b

A

Type-1 Interferons
30% aa identity
Bind to same receptor
Induce similar biological activities
Aka acid stable interferons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

IFN-y

A

Type ll Interferon
Binds to separate receptors & induce diff range of biological activity than a,b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Type l Interferon

A

-antiviral activity
- anti-proliferative effect on tumours & cells
-anti tumour effects: due to increase in NK & T-cytotoxic cell activity, which recognise & kill cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Type ll Interferon

A

-IFN-y has weak antiviral, anti proliferative activity
- co admin with type l gives antiviral & anti proliferative effect of a/b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

IFN-y promotes

A

Growth & differentiation in cells that include immune & inflammatory responses
Main macrophage activating factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

IFN-y macrophage mediated effects

A

-destruction of invading microbes
-destruction of intracellular pathogens
-tumour cytotoxicity
-increased major histocompatibility complex MHC antigen expression-> enhanced activity of lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Interferon biotech

A

Identified 1950
Initially impractical: low levels produced in body
Large scale purification, not viable
Exhibit species preference human-human

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Interferons 1970s

A

In small quantities
From human leukocytes from transfused blood supplies
Prep was only 1% pure
Consisted on various IFN-as (15+)

17
Q

Large scale interferon production

A

Mammalian cell culture
Cancer cell lines secret larger amounts of IFN
Good for large scale culture due to transformed nature

18
Q

Interferon biotech
Namalwa Cell line
Tradename: Wellferon

A

First approved
9 IFN-a pure subtypes
Human lymphoblastoid cells
Cells propagated up to 8000L
Addition of Sendai virus
Result: significant quantities of leukocyte interferon

19
Q

1980 y-immunex

A

Recombinant DNA
Large quantity
Pure interferon, only one subtype
(rh) produced by E.coli
Lacks PTM compensates that IFN-a/b are normally not glycosolated
IFN-y: is glycosolated, e.coli unglucosolated similar to native human protein

20
Q

Production & medical use of IFN-a

A

-Multi component, impure IFN-a preps induce regression of tumours in breast cancer, lymphoma, multiple myleloma
- delay reoccurrence if tumours after surgery for osteo sarcoma

21
Q

First recombinant interferon clinical studies
IFN-a2a properties

A

Anti- tumour
Anti-viral
Immunomodulatory

rhlFN-a2a / a2b Approved for:
-hairy cell leukaemia
-90% patients

22
Q

IFN-a2b Intron A

A

Schering Plough, first approved 1986
Hairy cell leukaemia
Now up to 16 uses
Produced by E.coli (KMAC-43)
Contains phosphate buffer, glycine & human albumin
Dose: 3,5,10,18,25,59 million IU/vial
Treats HEP B & C

23
Q

Modified INF-as examples

A

PEGlyated interferons: eg PEG Intron A, ViraferonPeg
Synthetic Interferons: eg Infergen

24
Q

viraferonPeg

A

PEGlyated INF-a2b, differs from human by covalent attached PEG
Marketed by Schering Plough
Treats Hep C in adults
Prolonged plasma half life (13-25 hours)

25
Q

Infergen IFN-a2b

A

Engineered & approved for Hep C
AA sequence reflects most most frequent as rescue in native interferon

26
Q

Medical use IFN-b

A

Treat relapsing-remitting multiple sclerosis (damage of myelin sheath) (20-40 year old)
IFN-b inhibits IFN-a & IFN-y: mediates down regulation of pro inflammatory response

27
Q

IFN-b approved drugs

A

Betaferon
Betaseron
Avonex
Rebif

Reduce frequency of relapse by 30%

28
Q

Medical use IFN-y

A

Treat chronic granulomatous disease (CGD)
Patients can’t ingest or destroy bacteria or Protozoa = repeat infections